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In this article I provide an overview of the moral and medical questions surrounding the 
use of cognitive enhancers. The discussion will be framed in light of four key 
considerations (1) is there a difference between therapy and enhancement? (2) How safe 
are these interventions? (3) Is the use of nootropics cheating? (4) Will enhancers create a 
further divide of social inequality where only the very wealthy will have access to them?  
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Case: Peter's mother brought him to his pediatrician to request she prescribe 
Ritalin. Peter is getting ready to take the ACT and the family wants him to do well 
because he wants to be admitted to the aerospace engineering program at MIT. 
 
The desire to improve oneself is not a new concept or even something that seems 
terribly controversial.  Stroll down an aisle in a bookstore and you will encounter an 
entire section dedicated to a range of self help topics: how to be happier, thinner, more 
spiritual, wealthier, smarter, more outgoing, the list is seemingly endless. Very few 
people regard such self-help tactics as untoward let alone unethical or illegal. This 
perspective is not necessarily shared, however, when it comes to the role of improvement 
via cognitive enhancers, also known as nootropics. Sometimes called cosmetic 
neurology, it refers to the use of drugs or devices that can improve cognition, executive 
function, memory, and even mood states.  
The legitimacy of cognitive enhancement raises a series of questions that involve 
ethics, medicine, the law, and public policy. In this paper I provide a general overview of 
cognitive enhancers, examine the various arguments for and against their use, and frame 
the discussion in light of four key considerations (1) is there a difference between therapy 
and enhancement? (2) How safe are these interventions? (3) Is the use of nootropics 
cheating? (4) Will enhancers create a further divide of social inequality where only the 
very wealthy will have access to them?  
It should be addressed at the outset that there is, as yet, no “smart pill” that will 
transform one into a genius. There are various methods that can, however, enhance our 
faculties, some of which are products of the new millennium and others date back for 
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centuries. A number of interventions have already gained acceptance in improving 
learning, enhancing memory, and affecting emotion. These include brain-training games, 
mnemonics, tutors, education and even smart phones. The same could be said of some 
dietary choices including chocolate or coffee, (or for a comprehensive experience, a 
mocha latte) which are also regarded as unproblematic. Other enhancers are more 
controversial and include drugs like dextroamphetamine (Adderall), methylphenidate 
(Ritalin) or modafinil (Provigil) that can enhance cognitive and affective function of the 
brain even in the absence of pathology. Enhancement devices include brain stimulation 
through the use of Transcranial Direct Current Stimulation (tDCS), and even implantable 
brain chips.  
 
Which are these types of enhancers and who is using them? 
Over the past few years, research directed toward treating or preventing cognitive 
decline due to neurodegenerative disorders has increased exponentially. Some of the 
medications developed to treat Alzheimer disease and Parkinson disease, for example, 
have had the unanticipated side effect of enhancing cognition in those without 
impairment.
1
 Drugs used to treat Attention Deficit Hyperactivity Disorder (ADHD) 
including Adderall and Ritalin are also reported to enhance working memory, problem 
solving and mathematical processing in healthy individuals.
2
 Modafinil (Provigil) is a 
eugeroic prescribed for narcolepsy or for those with erratic sleep patterns due to shift 
work. It is also reported to effect vigilance, wakefulness, and concentration in healthy 
individuals. It is perhaps little surprise that drugs touted to maintain alertness would 
become popular in the high stress and competitive environment of academia. It has been 
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reported that between 5-35% of college students and 8% of high school seniors have used 
these stimulants over a one-year period.
3
, 
4
 
In addition to increasing memory and concentration, one study suggests that such 
drugs can also significantly influence emotional states.
5
 University students who were 
non-medical users of Adderall or Ritalin were asked to provide detailed narratives of 
their experiences. A trend emerged where students reported feeling more motivated, 
interested, and engaged with their work and found the assignments they were tasked with 
to be significantly less tedious and more enjoyable when taking such drugs. While 
professors would certainly appreciate more engaged and interested students, one might be 
inclined to wonder if getting such results from a pill does not sound a bit dystopian.   
The use of cognitive enhancers is not limited to college students, however, as data 
indicate their professors may also be utilizing such drugs as well. An informal poll of the 
readers of the journal Nature, composed largely of academics, reveals that 20% had used 
cognitive enhancement at some point.
6
 Cognitive enhancers are also popular in the 
business sector as well as with the United States military. The United States Defense 
Advanced Research Projects Agency (DARPA) has a long history of investing in 
cognitive enhancement research to aid those engaged in lengthy field operations. 
However, the use of nootropics was implicated as the cause of „friendly fire‟ in 2002 
when US pilots killed Canadian troops. The event was blamed on the usage of “go pills” 
that apparently caused the pilots to become paranoid.
7
 
Transcranial direct current stimulation (tDCS) is a type of non-invasive brain 
stimulation that uses small jolts of electricity to focus on specific regions in the brain to 
excite neurons. It is used to encourage neural plasticity to treat a number of conditions 
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ranging from depression to stroke to traumatic brain injury.
8
 There is some literature that 
indicates it has a positive effect on learning for those who do not suffer any impairment.
9
 
These devices are now portable and can be used for personal use at home without 
professional oversight.  Some have noted that well-intentioned parents might use tDCS 
on their children despite the unknown effects on a developing brain.
10
 
The virtues of cognitive enhancement have been extoled and often hyperbolized 
in the popular media. They have been dubbed “steroids for the brain” and “Viagra for the 
brain” as well as dramatized in popular films like Limitless.11 The Food and Drug 
Administration does not approve of any drug solely for enhancement purposes. 
Therefore, while companies are not permitted to market their drugs for enhancement, it is 
legal for physicians to prescribe them off label as they see fit.
12
 This puts physicians in a 
challenging role as gatekeepers for a class of drugs that have not been evaluated for 
safety or efficacy for the purposes of neurologic enhancement. In addition, an 
unscrupulous patient can consult any number of websites that advise how to effectively 
feign symptoms in order to get a legitimate prescription.
13
 For those who prefer online 
shopping as opposed to doctor shopping, there is a growing black market where intrepid 
consumers can purchase drugs online without a prescription. The authenticity and safety 
of such drugs are unknown. 
Some studies suggest that cognitive enhancement is exaggerated and may be little 
more than the placebo effect. While these drugs can inarguably keep one awake longer to 
complete a task, there is little data at present to conclude that they improve one‟s 
performance in that task.  It is inherently difficult, however, to test how much 
enhancement a drug or device may provide given the various types of assessments and 
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measurements used.
14
 It has been suggested that individuals may experience 
enhancement on a spectrum with those with the poorest baseline performance showing 
the most gains.   
Interestingly, nicotine has been shown to significantly improve concentration 
much more so than the current class of nootropics. “The cognitive-enhancing effects of 
nicotine in a normal population are more robust than you get with any other agent. With 
Provigil, for instance, the evidence for cognitive benefits is nowhere near as strong as it is 
for nicotine.”8 In addition to enhancing learning, dozens of studies show nicotine may aid 
in the treatment of a host of psychiatric and neurological diseases.
15
 Ironically, though 
nicotine patches fail for their FDA approved use in quitting smoking they may be 
effective in treating Parkinson disease, Tourrette syndrome, and schizophrenia.  
 
Assessing therapy vs. enhancement  
Even if nootropics are in their relative infancy it is clear that effective enhancers 
are on the horizon and we ought to consider the particular questions they raise sooner 
rather than later. The first question is whether such drugs ought to be regarded as 
treatment for disease, and therefore should be covered by insurance, or as enhancement 
and considered in the same realm as vitamins and dietary supplements? This dichotomy 
would accept nootropics as therapy for those who have a medical diagnosis, such as 
Ritalin for a patient with ADHD, and reject them for recreational use (an individual who 
desires to stay up all night to meet a deadline). But drawing distinctions between therapy 
and enhancement is notoriously hazy and even morally problematic.  
 7 
A frequently cited example that illustrates the failure of this model is the use of 
human growth hormone therapy for two boys with short stature.
16, 17
 In this scenario one 
boy is short because he has a growth hormone deficiency as a result of a brain tumor and 
the other is short because he has very short parents. The first boy would receive growth 
hormone under the label of therapy while it would be considered enhancement for the 
second boy despite the fact both are afflicted by the same condition.  But if being short 
causes difficulty for males, including employment discrimination, limitations in partner 
selection, and less reproductive success, then it is not clear why treating the second 
condition should be considered enhancement.
18, 19
  
The trend toward over medicalization further contributes to the ambiguity in 
defining treatment versus enhancement. Medicalization in this context occurs when 
newly developed pharmaceuticals serve as the motivating factor to create new 
classifications of disease. This was clearly seen by the drug Viagra and the subsequent 
creation of the diagnosis of erectile dysfunction.
20
 Viagra was originally intended as a 
cardiovascular drug but had the unanticipated side effect of improving sexual 
performance, earning it the moniker the “Pfizer Riser” and over a billion dollars in sales.   
But is Viagra a treatment for the heretofore-unknown disorder of erectile 
dysfunction or is it enhancement? Sexual function naturally decreases as men age and if a 
middle-aged man cannot perform to the degree he could at age 21 is that a normal 
consequence of the aging process or is he sick and in need of treatment? What constitutes 
erectile dysfunction seems to greatly depend on one‟s notion of what “normal” erectile 
function should be, but if normal can be improved we are left without an objective 
baseline for which to determine whether something constitutes treatment or enhancement. 
 8 
Regenerative medicine including tissue engineering could equally be labeled as 
enhancement while whole organ transplantation, once a fantasy of science fiction, is now 
considered treatment. The difference between enhancement and treatment lacks clarity, 
and terms like “normal” or “average” become meaningless as the state-of-the-art 
continually improves. Further, some could claim that restoration of natural function is de 
facto therapy and not enhancement, but what of a 70 year-old postmenopausal female 
who desires to be pregnant?
21
 Should restoring her fertility be regarded treatment in the 
way Viagra is treatment for 70 year-old men? Concepts of health and illness are not 
simply objective classifications but are largely culture bound and reflect the biases and 
social norms of the current society. A review of the Diagnostic and Statistical Manual of 
Mental Disorders (DSM) from previous editions to its current version clearly 
demonstrates that nosology is, to a large degree, a social construct.  
 
Safety concerns 
Safety concerns are often cited as the reason to summarily reject the use of 
nootropics and associated interventions. Ritalin and Adderall can cause negative side 
effects including addiction, heart problems, nausea, anorexia, anxiety, and insomnia. 
They have been linked to cerebrovascular disease and as potential triggers for underlying 
mental illness.
22
 This perspective suggests that the delicate human brain may not tolerate 
fluctuations in neurochemistry by powerful pharmaceutical agents. Long-term safety is 
unknown leading some to argue that the small gains they may provide are not worth the 
risk when there are established strategies to improve physical and mental health. Studies 
show that diet, proper sleep, and exercise, particularly aerobic exercise, improves 
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cognitive function.
23
 With a growing obesity epidemic and nearly one third of Americans 
suffering some degree of sleep deprivation, the modification of health habits alone could 
be an enormous gain in public health. 
Another safety concern is that “more” may not always be “better” in terms of 
memory or attentiveness as it could lead to unanticipated problems. Altering the selective 
process of memory could carry associated effects where gains in one area may lead to 
diminishments in another. For example, mice that had been genetically engineered for 
increased learning ability also showed greater sensitivity to pain.
16
 Some studies have 
shown that Adderall may increase focus and attention but might actually reduce 
creativity.
24
 Another concern is that it may not be possible to simply amplify memory or 
cognition without having profound effects on our identity. The progression of Alzheimer 
disease shows the intricate relationship between memory and executive function to an 
individual‟s sense of self. As Alzheimer disease ravages the mind it is often seen to 
change the person.  Would enhancement have similar consequences on identity? Once 
enhanced, would one have the same interests, hobbies, or sense of humor? Will the 
person on “brain steroids” be the same person she was without?25 
In response to these criticisms, others would claim that it is inherently 
paternalistic to restrict nootropics on the basis of safety as long as individuals are fully 
apprised of the consequences.
26
 Perhaps there is even an undercurrent of hypocrisy found 
in the safety argument given our preoccupation and adulation of professional athletes, 
many who participate in violent sports. Football, boxing, and hockey all carry varying 
degrees of harm to those who participate yet are tremendously popular with the general 
public.  Football players suffer repeated traumatic brain injuries that can lead to 
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neurodegenerative disease yet few people would rally for a change to flag football. 
Crowds cheer and networks replay the most impressive (and dangerous) tackles, checks, 
and punches.  According to this perspective, many activities that are dangerous are not 
automatically banned, thus responsible discussion of regulation may be a better response 
than blanket prohibition.
26
 
Still others argue that similar safety concerns apply to those enrolled in highly 
competitive academic honors programs. The students in these programs are often under 
intense pressure to succeed, which could take a toll on their mental and physical health. 
Some side effects of high-pressure academic programs may include insomnia, dyspepsia, 
headache, anorexia, etc., which mirror many of the side effects documented from 
prescription stimulants.
27
 In addition, this perspective argues that enhancers pose no more 
a threat to health than participating in highly selective educational programs where 
academic demands may become all consuming. 
 
Is it cheating? 
Perhaps the most morally problematic argument against the use of nootropics is 
that it constitutes a form of cheating. For some, the idea of taking a pill to concentrate, to 
stay awake longer to study for an exam, or to meet a deadline is regarded as inauthentic 
and diminishes the hard work of those who put in the effort naturally. Some have worried 
that it deforms our character and devalues the spirit of perseverance and self-discipline.
17
 
Accordingly, if achievements come too easily and without a substantial investment of 
time and struggle, this could have the paradoxical effect of dampening the ambition 
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necessary to overcome future challenges and obstacles. Most of the discussions on 
cheating have focused on how it would apply in an academic setting. 
Universities have academic codes of conduct that prohibit cheating and plagiarism 
but have yet to directly address the use of cognitive enhancers as violations of academic 
integrity since they are regarded in a moral gray zone.  The President‟s Council on 
Bioethics has claimed the use of nootropics is “cheap” and compares those who use them 
with plagiarists, implying that work produced under the influence of nootropics is “less 
one‟s own and less worthy of our admiration.”2 Goodman, an opponent of this point of 
view, argues that it is precisely this cultural hegemony that regards cognitive 
enhancement as something immoral and undignified that keeps most people from using 
them. He recounts the collective moral outrage that followed after major league baseball 
player Barry Bonds admitted to steroid use and suggests that social conventions reinforce 
compliance but do not necessarily rely on any sound justification. 
Goodman further argues that to assume using nootropics is cheating requires that 
we regard accomplishment in the most narrow of terms, one that focuses solely on the 
individual.
2
 His alternate view suggests that accomplishment is not exclusively the result 
of the individual but could be seen as a collaborative process, one where outside social 
and cultural influences shape the product. This collaborative process is clearly seen 
across centuries from art and literature to philosophy and music. No one person can take 
credit in this model, instead ideas are developed and refined over time and passed down 
through tradition. Cognitive enhancers become yet another type of influence, though 
Goodman claims they ought not be hidden, they should be disclosed as readily as if one 
collaborated with another author.  
 12 
Still, others would argue that labeling nootropics as cheating solely on the basis 
that they confer particular cognitive advantages is insufficient since the institution of 
education attempts to impart the same goals. Education, like drugs, can have a profound 
physical effect on the brain by changing neuronal connections, which affect memory and 
information processing. According to this position, education is a benefit, not only to the 
individual but also to society at large, and to label one form of enhancement as acceptable 
but another as immoral requires justification that has not been forthcoming.
27
  
Olthof et al argue that education, and in particular, honors programs, seek to 
modify, expand, and enhance a select cadre of students and such programs are considered 
not only legitimate, but perhaps the hallmark of academic excellence.  Honors programs 
target the best and brightest not solely to develop individual talent but with the 
expectation that individuals will contribute to the “knowledge economy.”27 It is difficult, 
then, to make clear distinctions between what are acceptable methods of improvement 
and what are considered cheating.  
Some have argued that zero sum games where an individual is ranked according 
to the performance of her peers may require a different paradigm for the use of 
enhancers. If individuals are assessed based on individual performance rather than in 
relation to those of his or her peers then the issue of cheating is moot. Olthof et al argue it 
is the method of assessment that determines whether an intervention ought to be 
considered cheating more so than the type of enhancer. To the President‟s Council‟s 
concern that we risk losing our character if studying becomes too easy through the use of 
enhancers, an alternative view is to regard enhancers not as “smart pills” but as 
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augmenters to the educational process similar to the use of calculators or computers in the 
classroom.  
 
Equal Access  
The final issue under consideration is whether the use of nootropics would worsen 
social inequality. Buchanan argues that this will depend primarily on the kinds of 
interventions that are considered in the category of enhancement.
28
 Implantable brain 
chips or embryonic screening, for example, will likely remain expensive and available to 
a small few. Addressing the issue of genetic improvement and unequal access, Princeton 
biologist Lee Silver has suggested the possibility that this could lead to a genetic 
aristocracy where wealth would ensure health and disease would be confined to the 
poor.
29
 If, however, enhancement refers to drugs and other low impact interventions like 
tDCS then economic concerns are less problematic.
28
 A related concern is that some may 
feel pressured to take nootropics if they become readily available in order to remain 
competitive in an enhanced society. Further, some employers may require use of 
enhancers such as the military, medicine, and aviation. Much of this discussion remains 
speculative but a climate of enhancement would require safeguards to protect individual 
autonomy. 
 
Looking toward the future 
Along the spectrum of cognitive enhancers are pharmaceuticals designed 
specifically to diminish functions including memory, attachment, and even sexual 
function.  Some philosophers have endorsed diminishment as enhancement under a 
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Welfarist claim that the definition of enhancement should be broad enough in scope to 
include biological or psychological changes that promote one‟s welfare under a particular 
set of circumstances.
30
  
Accordingly, Earp et al argue that some drugs that reduce function actually 
enhance quality of life. For example, anti-love drugs may benefit a battered spouse who 
cannot otherwise break his or her emotional connection to an abuser. Victims of violent 
crimes can be relieved of traumatic memories and could benefit from drugs that attenuate 
their emotional content. Sex offenders often have the option of chemical castration as 
conditions for parole.
30
 
On a potentially brighter note (depending on one‟s point of view) love drugs are 
currently being investigated to reinforce the bond between couples that might otherwise 
dissolve over time.
31
 These interventions raise their own attendant concerns but it is clear 
that the next generation of cognitive enhancement is under way, which means the 
questions addressed herein will have to shift to the level of public policy.  
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